920 related articles for article (PubMed ID: 18254066)
21. Antiviral prophylaxis of neonatal herpes infection.
Záhumenský J; Vlácil J; Holub M; Vasícka I; Sojková N; Halaska M
Prague Med Rep; 2010; 111(2):142-7. PubMed ID: 20654004
[TBL] [Abstract][Full Text] [Related]
22. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
23. Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF).
Sénat MV; Anselem O; Picone O; Renesme L; Sananès N; Vauloup-Fellous C; Sellier Y; Laplace JP; Sentilhes L
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():93-101. PubMed ID: 29571124
[TBL] [Abstract][Full Text] [Related]
24. Preventing herpes simplex virus transmission to the neonate.
Brown Z
Herpes; 2004 Aug; 11 Suppl 3():175A-186A. PubMed ID: 15319088
[TBL] [Abstract][Full Text] [Related]
25. Antiviral agents for infectious mononucleosis (glandular fever).
De Paor M; O'Brien K; Fahey T; Smith SM
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011487. PubMed ID: 27933614
[TBL] [Abstract][Full Text] [Related]
26. Update on antiviral therapy for genital herpes infection.
Geers TA; Isada CM
Cleve Clin J Med; 2000 Aug; 67(8):567-73. PubMed ID: 10946451
[TBL] [Abstract][Full Text] [Related]
27. Acyclovir prophylaxis in late pregnancy prevents recurrent genital herpes and viral shedding.
Braig S; Luton D; Sibony O; Edlinger C; Boissinot C; Blot P; Oury JF
Eur J Obstet Gynecol Reprod Biol; 2001 May; 96(1):55-8. PubMed ID: 11311761
[TBL] [Abstract][Full Text] [Related]
28. No. 208-Guidelines for the Management of Herpes Simplex Virus in Pregnancy.
Money DM; Steben M
J Obstet Gynaecol Can; 2017 Aug; 39(8):e199-e205. PubMed ID: 28729112
[TBL] [Abstract][Full Text] [Related]
29. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
Schuster AK; Harder BC; Schlichtenbrede FC; Jarczok MN; Tesarz J
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011503. PubMed ID: 27841441
[TBL] [Abstract][Full Text] [Related]
30. Prevention, recognition and management of neonatal HSV infections.
Robinson JL; Vaudry WL; Forgie SE; Lee BE
Expert Rev Anti Infect Ther; 2012 Jun; 10(6):675-85. PubMed ID: 22734957
[TBL] [Abstract][Full Text] [Related]
31. WITHDRAWN. Antiviral treatment for Bell's palsy (idiopathic facial paralysis).
Gagyor I; Madhok VB; Daly F; Somasundara D; Sullivan M; Gammie F; Sullivan F
Cochrane Database Syst Rev; 2015 May; (5):CD001869. PubMed ID: 25938618
[TBL] [Abstract][Full Text] [Related]
32. Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.
Kimberlin DW; Baley J; ;
Pediatrics; 2013 Feb; 131(2):383-6. PubMed ID: 23378604
[No Abstract] [Full Text] [Related]
33. Antiviral therapy for genital herpes in nonpregnant and pregnant women.
Baker DA
Int J Fertil Womens Med; 1998; 43(5):243-8. PubMed ID: 9863617
[TBL] [Abstract][Full Text] [Related]
34. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Hodson EM; Ladhani M; Webster AC; Strippoli GF; Craig JC
Cochrane Database Syst Rev; 2013 Feb; (2):CD003774. PubMed ID: 23450543
[TBL] [Abstract][Full Text] [Related]
35. [Mother-infant and indirect transmission of HSV infection: treatment and prevention].
Henrot A
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323
[TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
37. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
[TBL] [Abstract][Full Text] [Related]
38. Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts.
Bhatt UK; Abdul Karim MN; Prydal JI; Maharajan SV; Fares U
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007824. PubMed ID: 27902849
[TBL] [Abstract][Full Text] [Related]
39. Genital herpes: antiviral therapy for symptom relief and prevention of transmission.
Gupta R; Wald A
Expert Opin Pharmacother; 2006 Apr; 7(6):665-75. PubMed ID: 16556084
[TBL] [Abstract][Full Text] [Related]
40. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
